Article Text

Download PDFPDF
Review
Outcomes following surgical versus endovascular treatment of spinal dural arteriovenous fistula: a systematic review and meta-analysis
  1. Anshit Goyal1,
  2. Joseph Cesare1,
  3. Victor M Lu1,
  4. Mohammed Ali Alvi1,
  5. Panagiotis Kerezoudis1,
  6. Waleed Brinjikji2,
  7. Deena Nasr3,
  8. Guiseppe Lanzino1,
  9. Mohamad Bydon1
  1. 1 Neurosurgery, Mayo Clinic, Rochester, Minnesota, USA
  2. 2 Radiology, Mayo Clinic, Rochester, Minnesota, USA
  3. 3 Neurology, Mayo Clinic, Rochester, Minnesota, USA
  1. Correspondence to Dr Mohamad Bydon, Neurosurgery, Mayo Clinic, Rochester, MN 55905, USA; bydon.mohamad{at}mayo.edu

Abstract

Although surgical resection is associated with a complete cure in most cases of spinal dural arteriovenous fistulas (SDAVF), there has been an increasing trend towards embolisation. We performed a systematic review and meta-analysis comparing surgical resection with endovascular treatment in terms of success of treatment, rate of recurrence and complications. A literature search was conducted using Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Strength of evidence was assessed using the Grading of Recommendations Assessment, Development and Evaluation Working Group system. Surgical outcomes such as initial treatment failure, late recurrence, neurological improvement and complications were compared between the two approaches. We included 57 studies with 2029 patients, of which 32 studies with 1341 patients directly compared surgery (n=590) and embolisation (n=751). Surgery was found to be associated with significantly lower odds of initial treatment failure (OR: 0.15, 95% CI 0.09 to 0.24, I2 0%, p<0.001) and late recurrence (OR 0.18, 95% CI 0.09 to 0.39, I2 0%, p<0.001). The odds of neurological improvement following surgery were also significantly higher compared with embolisation alone (OR: 2.73, CI:1.67 to 4.48, I2 :49.5%, p<0.001). No difference in complication rates was observed between the two approaches (OR 1.78, 95% CI 0.97 to 3.26, I2 0%, p=0.063). Onyx was associated with significantly higher odds of initial failure/late recurrence as compared with n-butyl 2-cyanoacrylate (OR: 3.87, CI: 1.73 to 8.68, I2 :0%, p<0.001). Surgery may be associated with superior outcomes for SDAVFs in comparison to endovascular occlusion. Newer embolisation agents like Onyx have not conferred a significant improvement in occlusion rate.

  • spinal dural arteriovenous fistulas
  • SDAVF
  • arteriovenous malformations
  • endovascular
  • embolisation
  • surgery
  • treatment failure
  • recurrence
  • complications
  • systematic review
  • meta-analysis
View Full Text

Statistics from Altmetric.com

Footnotes

  • Contributors AG Conceptualisation and design, data collection, analysis and drafting of manuscript. JC Conceptualisation and design, data collection, analysis and drafting of manuscript. VML reviewing and revising original draft. MAA reviewing and revising original draft. PK reviewing and revising original draft. WB reviewing and revising original draft. DMN reviewing and revising original draft. GL reviewing and revising original draft. MB study supervision, reviewing and revising original draft.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent for publication Not required.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.